Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge Pharmaceutical Investing
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022 Pharmaceutical Investing
Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation Pharmaceutical Investing
AbbVie Announces Submissions of Regulatory Applications for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Large B-Cell Lymphoma Pharmaceutical Investing
Obsidian Therapeutics Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb Pharmaceutical Investing
New Zeposia Data Highlight COVID-19 Outcomes and Preservation of Long-Term Cognitive Function from Separate Analyses in Patients with Relapsing Forms of Multiple Sclerosis Pharmaceutical Investing
